Realtime | Geld | Brief | Zeit |
---|---|---|---|
46,420 | 46,920 | 05.12. | |
46,550 | 46,820 | 05.12. |
Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
Do | Eurofins Scientific SE: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at 30 November 2024 | 159 | Business Wire |
Regulatory News:
Eurofins (Paris:ERF):
ANNEXE B Form to be used for the disclosure of the total number of voting rights and capital, in accordance with the law and grand-ducal regulation... ► Artikel lesen | |
Mo | Eurofins: Purchases of Own Shares from November 25th to November 29th, 2024 | 276 | Business Wire | Regulatory News:
Eurofins (Paris:ERF):
Name of the Issuer Identity code of the Issuer Day of the transaction Identity code of the financial instrument Total... ► Artikel lesen | |
25.11. | Eurofins: Purchases of Own Shares From November 18th to November 22th, 2024 | 94 | Business Wire | Regulatory News:
Eurofins (Paris:ERF):
Name of the Issuer Identity code of the Issuer Day of the transaction Identity code of the financial instrument Total daily volume (in number... ► Artikel lesen | |
25.11. | Eurofins Sustainability Services Introduces CleanAir Check Service for Volatile Organic Compounds (VOCS) Testing | 30 | Business Wire | Advanced analytical techniques aligned with ZDHC Air Emissions Guidelines to detect VOCs and additional prohibited compounds. Eurofins Sustainability Services, a full-service provider for retailers... ► Artikel lesen | |
18.11. | Eurofins Scientific SE: Purchases of Own Shares From November 11th to November 15th, 2024 | 53 | Business Wire | Regulatory News:
Eurofins Scientific SE (Paris:ERF):
Name of the Issuer Identity code of the Issuer Day of the transaction Identity code of the financial instrument... ► Artikel lesen | |
13.11. | Eurofins Scientific SE: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at 31 October 2024 | 282 | Business Wire | Regulatory News:
Eurofins Scientific SE (Paris:ERF):
ANNEXE B Form to be used for the disclosure of the total number of voting rights and capital, in accordance with the law and grand-ducal... ► Artikel lesen | |
12.11. | Eurofins: Purchases of Own Shares from November 04th to November 08th, 2024 | 315 | Business Wire | Regulatory News:
Eurofins (Paris:ERF):
Name of the Issuer Identity code of the Issuer Day of the transaction Identity code of the financial instrument Total... ► Artikel lesen | |
09.11. | Eurofins Scientific Aktie: Innovation auf der Überholspur! | 702 | Börse Global | Die Eurofins Scientific Aktie zeigt sich zum 9. November 2024 mit einem Kurs von 45,87 EUR weitgehend stabil. Im vergangenen Monat konnte das Papier des führenden Bioanalytik-Unternehmens einen leichten... ► Artikel lesen | |
EUROFINS SCIENTIFIC Aktie jetzt für 0€ handeln | |||||
04.11. | Eurofins: Purchases of Own Shares From October 28th to November 1st, 2024 | 279 | Business Wire | Regulatory News:
Eurofins (Paris:ERF):
Name of the Issuer Identity code of the Issuer Day of thetransaction Identity code of the financialinstrument Total daily volume (innumber... ► Artikel lesen | |
30.10. | Eurofins erwirbt das klinische Diagnostikgeschäft von SYNLAB in Spanien | 46 | Bionity.com | ||
28.10. | Eurofins: Purchases of Own Shares from October 21th to October 25th, 2024 | 349 | Business Wire | Regulatory News:
Eurofins (Paris:ERF):
Name of the Issuer Identity code of the Issuer Day of the transaction Identity code of the financial instrument Total... ► Artikel lesen | |
28.10. | Eurofins Agrees to Acquire SYNLAB's Clinical Diagnostics Operations in Spain | 598 | Business Wire | Regulatory News:
Eurofins (Paris:ERF):
Eurofins Scientific (EUFI.PA), a global scientific leader in bioanalytical testing, with a rapidly developing presence in highly specialised and molecular... ► Artikel lesen | |
23.10. | Earnings call: Eurofins optimistic despite Q3 softness, aims for long-term growth | 73 | Investing.com | ||
22.10. | Eurofins Scientific says financial audit refutes short seller allegations | 75 | Investing.com | ||
22.10. | Eurofins Scientific Stock: Robust Growth Amidst Market Challenges | Börse Global (english) | |||
22.10. | Eurofins Scientific SE: Eurofins Confirms Profitability and Cash Flow Objectives for 2024 Leading to Higher Profit Margins in Spite of the Impact of the Post-COVID Reset of BioPharma Pipelines | 627 | Business Wire | Regulatory News:
Eurofins" (Paris:ERF) organic growth momentum remained robust in Q3 in most business lines:
Reported revenues in 9M 2024 reached €5,142m, +6.7% vs 9M 2023, supported by... ► Artikel lesen | |
22.10. | Eurofins Announces Results of Cash Audit Confirming Its FY 2023 Cash Balance and the High Integrity of Its Systems and Controls and Refutes Muddy Waters" Allegations Regarding Transactions That Occurred Between 10 and 25 Years Ago | 383 | Business Wire | Regulatory News:
Eurofins (Paris:ERF):
Eurofins Scientific (EUFI.PA), a global scientific leader in bioanalytical testing, announces that the additional independent forensic audit of Eurofins"... ► Artikel lesen | |
21.10. | Eurofins: Purchases of Own Shares from October 14th to October 18th, 2024 | 315 | Business Wire | Regulatory News:
Eurofins (Paris:ERF):
Name of the Issuer Identity code of the Issuer Day of the transaction Identity code of the financial instrument Total... ► Artikel lesen | |
14.10. | Eurofins: Purchases of Own Shares From October 7th to October 11th, 2024 | 327 | Business Wire | Regulatory News:
Eurofins (Paris:ERF):
Name of the Issuer Identity code of the Issuer Day of the
transaction Identity code of the financial
instrument Total... ► Artikel lesen | |
10.10. | Eurofins Discovery Extends AI-powered Integrated Drug Discovery Collaboration | 360 | Business Wire | 2nd Year Alliance with Dompé farmaceutici S.p.A. Eurofins Discovery, an industry-leading provider of products and services for drug discovery research, announced today the renewal of its collaboration... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
FRESENIUS | 33,970 | -0,09 % | Neue 11,00% Multi Aktienanleihe auf Bayer, BioNTech und Fresenius in Zeichnung | München (www.anleihencheck.de) - Die Experten vom Zertifikate-Team der Bank Vontobel Europe AG bieten eine neue Multi Aktienanleihe (ISIN DE000VC8M4R0/ WKN VC8M4R) mit Barriere (Worst-Of) Quanto auf... ► Artikel lesen | |
FRESENIUS MEDICAL CARE | 45,710 | +2,08 % | Fresenius Medical Care Aktie: Fortschritt kennt keine Grenzen | ||
SIEMENS HEALTHINEERS | 51,72 | -0,08 % | Siemens Healthineers Aktie: Ein positiver Ausblick! | ||
CARL ZEISS MEDITEC | 58,70 | +2,09 % | Carl Zeiss Meditec-Aktie mit Kursverlusten (56,70 €) | Im Minus liegt zur Stunde der Anteilsschein von Carl Zeiss Meditec . Der jüngste Kurs betrug 56,70 Euro. An der Börse liegt die Carl Zeiss Meditec-Aktie aktuell im Minus. Das Papier verbilligte sich... ► Artikel lesen | |
ECKERT & ZIEGLER | 47,420 | +2,64 % | Buy or Goodbye?: Die Analystenstimmen des Tages: Easyjet, CTS Eventim, Patrizia, Eckert & Ziegler | © Foto: Emmanuele Contini - picture alliance/NurPhoto/Emmanuele ContiniRBC hebt das Kursziel für Easyjet an. Während JJPMorgan hebt das Kursziel für CTS Eventim anhebt. Das sind die wichtigsten Analysten-Calls... ► Artikel lesen | |
DRAEGERWERK | 44,350 | -0,56 % | Draegerwerk Aktie: Jetzt wird es ungemütlich | Die Draegerwerk AG & Co. KGaA verzeichnet zum Ende des Novemberhandels eine verhaltene Entwicklung. Der aktuelle Aktienkurs liegt bei 43,53 EUR, was einem monatlichen Rückgang von 2,30 Prozent entspricht.... ► Artikel lesen | |
MEDTRONIC | 79,58 | -1,93 % | Acutus Medical announces operational downsizing to solely support Medtronic distro deal | ||
INTUITIVE SURGICAL | 517,70 | -1,01 % | (ISRG) - Analyzing Intuitive Surgical's Short Interest | ||
GERRESHEIMER | 75,00 | -0,27 % | Gerresheimer: Neue Werkshalle in Skopje stärkt globale Kapazitäten für Glasspritzen | Die Gerresheimer AG, ein führender System- und Lösungsanbieter für die Pharma-, Biotech- und Kosmetikindustrie, investiert massiv in die Erweiterung ihrer Produktionskapazitäten. In Skopje, Nordmazedonien... ► Artikel lesen | |
TELADOC HEALTH | 10,296 | -1,83 % | Out-of-consensus buy ideas according to Goldman: CAG, TRIP, TDOC | ||
UNITEDHEALTH | 545,80 | -6,06 % | Schock in Manhatten: UnitedHealth-Chef Brian Thompson erschossen! | © Foto: Stefan Jeremiah - dpaBrian Thompson, CEO von UnitedHealthcare, wurde am Mittwochmorgen vor dem Hilton Hotel in Midtown Manhattan erschossen.Ein tragisches Ereignis erschüttert die Gesundheitsbranche:... ► Artikel lesen | |
THERMO FISHER | 490,55 | -2,48 % | How Is Thermo Fisher Scientific's Stock Performance Compared to Other Medical Devices Stocks? | ||
STRATEC | 29,300 | -0,85 % | Stratec-Aktie: Kurs heute im Minus (30,40 €) | An der deutschen Börse liegt der Anteilsschein von Stratec gegenwärtig im Minus. Das Papier notiert aktuell bei 30,40 Euro. An der Börse liegt die Aktie von Stratec zur Stunde im Minus. Die Aktie verbilligte... ► Artikel lesen | |
TEMPUS AI | 53,12 | 0,00 % | Spotlight on Tempus AI: Analyzing the Surge in Options Activity | ||
NANO-X IMAGING | 6,230 | 0,00 % | Nano-X Imaging LTD.: Nanox.ARC Imaging System Receives FDA Clearance for General Use, Including Pulmonary Indication | Nanox.ARC receives additional FDA clearance to produce tomographic images for general use, including pulmonary, intra-abdominal and paranasal indications, in addition to its previously cleared indication... ► Artikel lesen |